BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ)

$0.1566 -0.0134 (-7.8824%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 72

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) News Sources

bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual "Advances in Early Lung Cancer Detection" Symposium April 16

07-04-2026

yahoo.com

New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy

14-04-2026

yahoo.com

bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?

16-04-2026

yahoo.com

bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment

28-04-2026

yahoo.com

bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung

08-05-2026

yahoo.com

bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026

12-05-2026

yahoo.com

BIAF Stock Slips Post Q1 Earnings Despite Strength in CyPath Lung

14-05-2026

yahoo.com

bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath® Lung Technology

27-05-2026

yahoo.com

Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies’ Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar

02-06-2026

yahoo.com

bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans

16-06-2026

yahoo.com

BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) Sentiment Trend

0 25 50 75 100 81 74 84 63 81 70 75 58 68 62 07-04-2026 14-04-2026 16-04-2026 28-04-2026 08-05-2026 12-05-2026 14-05-2026 27-05-2026 02-06-2026 16-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) FAQs

toggle

What is the current price of BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ)?

The current price of BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) is $0.1566.


toggle

BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) absolute price change since previous trading day?

The absolute price change of BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) since the previous trading day is $-0.0134.


toggle

BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) percentage price change since previous trading day?

The percentage price change of BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) since the previous trading day is -7.8824%.


toggle

What is the most recent average sentiment score for BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ)?

The most recent average sentiment score for BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) is 72 out of 100.


toggle

What is the most recent average sentiment for BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ)?

The most recent sentiment for BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) is .


SEC-8K** Filing Available For BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.